The human papillomavirus type 11 and 16 E6 proteins modulate the cell-cycle regulator and transcription cofactor TRIP-Br1

Virology

Volumn 317, Issue 1, 2003, Pages 155-164

  Gupta, Sanjay ^a   Takhar, Param Parkash S ^a   Degenkolbe, Roland ^a   Koh, Choon Heng ^a   Zimmermann, Holger ^a,d   Yang, Christopher Maolin ^b   Sim, Khe Guan ^b   Hsu, Stephen I Hong ^b   Bernard, Hans Ulrich ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; HUMAN PAPILLOMA VIRUS E6 PROTEIN; ONCOPROTEIN; PROTEIN DP1; PROTEIN P16; PROTEIN P16INK4A; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTIONAL REGULATOR INTERACTING WITH THE PHD BROMODOMAIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CONTROLLED STUDY; ENZYME REPRESSION; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MOTIF; TRANSCRIPTION INITIATION; TWO HYBRID SYSTEM; VIRUS STRAIN; WART VIRUS; YEAST;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MAMMALIA; PAPILLOMAVIRUS;

EID: 0346367059     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2003.08.008     Document Type: Article

References (37)

1. Chan S.Y., Delius H., Halpern A.L., Bernard H.U. Analysis of genomic sequences of 95 papillomavirus types uniting typing, phylogeny, and taxonomy . J. Virol. 69:(5):1995;3074-3083.
2. Chen J.J., Hong Y., Rustamzadeh E., Baleja J.D., Androphy E.J. Identification of an alpha helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273:(22):1998;13537-13544.
3. Das K., Bohl J., Vande Pol S.B. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP. J. Virol. 74:(2):2000;812-816.
4. Degenhardt Y.Y., Silverstein S. Interaction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation. J. Virol. 75:(23):2001;11791-11802.
5. Degenhardt Y.Y., Silverstein S.J. Gps2, a protein partner for human papillomavirus E6 proteins. J. Virol. 75:(1):2001;151-160.
6. Desaintes C., Hallez S., Van Alphen P., Burny A. Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 66:(1):1992;325-333.
7. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12:(15):1998;2245-2262.
8. Gewin L., Galloway D.A. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol. 75:(15):2001;7198-7201.
9. Howley, P.M., Ed., 1996. Papillomaviridae: the viruses and their replication, third ed, Fields, B.N., Knipe, D.M., Howley, P.M., (Eds.), Fields Virology, Lippincott-Raven, Philadelphia.
10. Hsu S.I., Yang C.M., Sim K.G., Hentschel D.M., O'Leary E., Bonventre J.V. TRIP-Br a novel family of PHD zinc finger- and bromodomain-interacting proteins that regulate the transcriptional activity of E2F-1/DP-1 . EMBO J. 20:(9):2001;2273-2285.
11. Huibregtse J.M., Scheffner M., Howley P.M. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell Biol. 13:(8):1993;4918-4927.
12. IARC, 1995. Human Papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans.
13. Khleif S.N., DeGregori J., Yee C.L., Otterson G.A., Kaye F.J., Nevins J.R., Howley P.M. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc. Natl. Acad. Sci. USA. 93:(9):1996;4350-4354.
14. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94:(21):1997;11612-11616.
15. Kuhne C., Banks L. E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. J. Biol. Chem. 273:(51):1998;34302-34309.
16. Kukimoto I., Aihara S., Yoshiike K., Kanda T. Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein. Biochem. Biophys. Res. Commun. 249:1998;258-262.
17. Lamberti C., Morrissey L.C., Grossman S.R., Androphy E.J. Transcriptional activation by the papillomavirus E6 zinc finger oncoprotein. EMBO J. 9:(6):1990;1907-1913.
18. Lee S.S., Weiss R.S., Javier R.T. Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94:(13):1997;6670-6675.
19. Mantovani F., Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene. 20:(54):2001;7874-7887.
20. Munger K., Basile J.R., Duensing S., Eichten A., Gonzalez S.L., Grace M., Zacny V.L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene. 20:(54):2001;7888-7898.
21. Myers G., Bernard H.U., Delius H., Favre M., Icenogle J., van Ranst M., Wheeler C. Human Papillomaviruses, II-E6-2-6. 1994;Los Alamos National Laboratory, Los Alamos, NM.
22. Ned R., Allen S., Vande Pol S. Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6. J. Virol. 71:(6):1997;4866-4870.
23. Patel D., Huang S.M., Baglia L.A., McCance D.J. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J. 18:(18):1999;5061-5072.
24. Rapp L., Chen J.J. The papillomavirus E6 proteins. Biochim. Biophys. Acta. 1378:(1):1998;F1-19.
25. Ronco L.V., Karpova A.Y., Vidal M., Howley P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 12:(13):1998;2061-2072.
26. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell. 75:(3):1993;495-505.
27. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:(6):1990;1129-1136.
28. Song S., Liem A., Miller J.A., Lambert P.F. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology. 267:(2):2000;141-150.
29. Sugimoto M., Nakamura T., Ohtani N., Hampson L., Hampson I.N., Shimamoto A., Furuichi Y., Okumura K., Niwa S., Taya Y., Hara E. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev. 13:(22):1999;3027-3033.
30. Trimarchi J.M., Lees J.A. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:(1):2002;11-20.
31. Ullman C.G., Haris P.I., Galloway D.A., Emery V.C., Perkins S.J. Predicted alpha-helix/beta-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. Biochem. J. 319:(Pt. 1):1996;229-239.
32. Vande Pol S.B., Brown M.C., Turner C.E. Association of bovine papillomavirus type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene. 16:(1):1998;43-52.
33. Werness B.A., Levine A.J., Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:(4951):1990;76-79.
34. Xiao J.H., Davidson I., Matthes H., Garnier J.M., Chambon P. Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1. Cell. 65:(4):1991;551-568.
35. Zimmermann H., Degenkolbe R., Bernard H.U., O'Connor M.J. The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J. Virol. 73:(8):1999;6209-6219.
36. Zimmermann H., Koh C.H., Degenkolbe R., O'Connor M.J., Muller A., Steger G., Chen J.J., Lui Y., Androphy E., Bernard H.U. Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J. Gen. Virol. 81:(Pt. 11):2000;2617-2623.
37. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim. Biophys. Acta. 1288:(2):1996;F55-F78.